Medicine and Dentistry
Human Respiratory Syncytial Virus
75%
Respiratory Tract Infection
51%
Diagnosis
50%
Flaccid Paralysis
42%
Infection
40%
Intensive Care Unit
37%
Poliomyelitis Virus
36%
Poliomyelitis
34%
Disease
31%
Toddlers
29%
Human Poliovirus 2
29%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Pediatrics
26%
Pathogen
25%
Systematic Review
25%
Medical Research
22%
Respiratory Syncytial Virus Infection
22%
Intensive Care
15%
Surveillance System
15%
Next Generation Sequencing
14%
Lower Respiratory Tract Infection
12%
COVID-19
12%
Respiratory Syncytial Virus
12%
Coronavirinae
12%
Molecular Diagnosis
12%
Clinician
12%
Bacterial Infection
12%
Disease Burden
12%
Cytomegalovirus Infection
12%
Wiskott-Aldrich Syndrome
12%
Radiation Therapy
12%
Malignant Neoplasm
12%
Cytomegalovirus
12%
Influenza
12%
Evolution
12%
Low and Middle Income Countries
9%
Paralysis
8%
Polymerase Chain Reaction
6%
Ganciclovir
6%
Breathing
6%
Immunoglobulin
6%
Infant Mortality
6%
Microcephaly
6%
Bacterial Pneumonia
6%
Viral Pneumonia
6%
Lung Tuberculosis
6%
Sclera
6%
Hepatosplenomegaly
6%
Virus Infection
6%
Coughing
6%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Poliomyelitis Virus
87%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Infectious Agent
32%
Human Poliovirus 2
31%
Lower Respiratory Tract
30%
Respiratory Syncytial Virus Infection
27%
Enterovirus
26%
Prevalence
20%
Next Generation Sequencing
17%
Cladistics
17%
Disease Burden
14%
COVID-19
14%
Infectious Disease
14%
One Health
12%
Blood Plasma
12%
Viral Zoonosis
12%
Virus Evolution
12%
Wild Type
12%
Zoonosis
12%
Molecular Epidemiology
12%
Cytokine
12%
Influenza
12%
Oral Poliomyelitis Vaccine
10%
Enterovirus B
9%
Polymerase Chain Reaction
7%
Staphylococcus Aureus
7%
Antiserum
6%
Cell Line
6%
Reverse Transcription Polymerase Chain Reaction
6%
Coinfection
6%
Phylogeny
6%
Immunity
5%
Influenza B Virus
5%
Haemophilus influenzae
5%
Influenzavirus A
5%
Virus Isolation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
100%
Poliomyelitis Virus
48%
Flaccid Paralysis
40%
Respiratory Tract Infection
39%
Poliomyelitis
34%
Disease
29%
Lower Respiratory Tract Infection
29%
Human Poliovirus 2
29%
Respiratory Syncytial Virus Infection
27%
Infection
16%
SARS Coronavirus
12%
Enterovirus
12%
Infectious Agent
9%
Paralysis
8%
Case Fatality Rate
8%
Oral Poliomyelitis Vaccine
5%